Cardiovascular outcomes of sodium glucose co-transporter-2 inhibitor treatment in cancer patients receiving anthracycline chemotherapy: a systematic review and meta-analysis

Back

ESC Professional Premium Access

Cardiovascular outcomes of sodium glucose co-transporter-2 inhibitor treatment in cancer patients receiving anthracycline chemotherapy: a systematic review and meta-analysis

Session: Cardio-oncology: around the world

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Doctor R. Cordovez (Cebu City, PH)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Rey Adam Cordovez

Vicente Sotto Memorial Medical Center, Cebu City (Philippines)

0 follower

5 more presentations in this session

Prognostic value of asymptomatic coronary artery disease and coronary artery calcium score for the risk of cancer therapy-related cardiac dysfunction (ANTEC study)

Speaker: Doctor A. Borowiec (Warsaw, PL)

Temporal trends and outcomes of amyloidosis in Korea: a 13-year nationwide cohort study with a focus on cardiac involvement

Speaker: Doctor M. Jung (Seoul, KR)

Echocardiographic assessment of early radiotherapy-induced cardiotoxicity in breast cancer patients

Speaker: Assistant Professor M. Cvijic (Ljubljana, SI)

P-Selectin - predictor of venous thromboembolism in cancer patients?

Speaker: Ms N. Diaconu (Chisinau, MD)

Endocarditis in patients with active malignant disease: a common condition with high rates of morbidity and mortality

Speaker: Mr K. Rakhimov (Berlin, DE)

Access the full session

Cardio-oncology: around the world

Speakers: Doctor R. Cordovez, Doctor A. Borowiec, Doctor M. Jung, Assistant Professor M. Cvijic, Ms N. Diaconu...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources